首页/数据集/MARV vaccines with protective efficacy in the preclinical NHP model.

MARV vaccines with protective efficacy in the preclinical NHP model.

Figshare2022-10-13 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/MARV_vaccines_with_protective_efficacy_in_the_preclinical_NHP_model_/21326188 数据链接链接失效反馈

官方服务：

资源简介：

MARV vaccines with protective efficacy in the preclinical NHP model.

应用场景：

创建时间：

2022-10-13

临床前药效评价

皮下给药药代动力学

Anagrelide (ANA) is a phosphodiesterase 3A (PDE3A) inhibitor, commonly prescribed for essential thrombocythemia. It also functions as a molecular glue, inducing complex formation between PDE3A and Sch

DataCite Commons2025-05-12 更新320

Single dose of a VSV-based vaccine rapidly protects macaques from Marburg virus disease

马尔堡病毒疫苗

快速免疫保护

Marburg virus (MARV) is a member of the filovirus family that causes hemorrhagic disease with high case fatality rates. MARV is on the priority list of the World Health Organization for countermeasure

NIAID Data Ecosystem60

Clinical parameters in the pilot study examining the efficacy of heme arginate (HA) and L-arginine (LA) in the db/db mouse model of type 2 diabetes.

糖尿病动物模型

临床前药效评价

Clinical parameters in the pilot study examining the efficacy of heme arginate (HA) and L-arginine (LA) in the db/db mouse model of type 2 diabetes.

NIAID Data Ecosystem40

In vivo safety profile in CIA mice treated with MFK902.

关节炎药物安全性

临床前药效评价

In vivo safety profile in CIA mice treated with MFK902.

NIAID Data Ecosystem60

Table 1 from Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN–Associated and Sporadic NF2-Deficient Meningiomas